Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 58 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
Heran HealthTech Fund II from Antwerpen, company number BE1015293753, closed financial year 2026 with a result of € -2.4 million after tax. For that financial year Heran HealthTech Fund II recorded a gross margin of € -2.3 million and equity of € 4.5 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 4.5 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2.4 million
Profit after tax over the fiscal year.
€ 299,518
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2.4 million.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 519,075
Supplier invoices still open on the last day of the fiscal year.
€ 1,153
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Heran HealthTech Fund II?
What happened at Heran HealthTech Fund II in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 2.4 million. Source: NBB ↗
- New establishment in Antwerpen. KBO
- Heran Partners II BV became a director. NBB
- Start of the company according to the CBE. KBO
A new publication or filing at Heran HealthTech Fund II? We notify you, reason included.
Follow Heran HealthTech Fund IIDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Heran HealthTech Fund II is Heran Partners II BV. It owns 25.1% of Fluidic Sciences Ltd and 16.3% of Pharmacelera SL itself.
Directors
According to the 2026 annual accounts
Manager · represented by Katleen Vandermissen
since 2024
Establishments
Establishment units
Physical locations of this company
Amerikalei 64 box 5
2000 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1015.293.753
- VAT number
- BE 1015.293.753
- Registered office
- Amerikalei 64 bus 5, 2000 Antwerpen
- Names & denominations
- Heran HealthTech Fund II
- Enterprise type
- Rechtspersoon
- Legal form
- Limited partnership
- Legal situation
- Normale toestand
- Start date
- 18 October 2024
- Peppol
- Active · Active since 7 Oct 2025
- Activities · NACE
Activiteiten van holdings
Holdings